Your search returned 2 results.

Results
	1.	Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. [electronic resource] by Marx, Nikolaus Froehlich, Johannes Siam, Laila Ittner, Jochen Wierse, Gerhard Schmidt, Arnold Scharnagl, Hubert Hombach, Vinzenz Koenig, Wolfgang Producer: 20030314 In: Arteriosclerosis, thrombosis, and vascular biology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. [electronic resource] by Marx, Nikolaus Imhof, Armin Froehlich, Johannes Siam, Laila Ittner, Jochen Wierse, Gerhard Schmidt, Arnold Maerz, Winfried Hombach, Vinzenz Koenig, Wolfgang Producer: 20030425 In: Circulation vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search